Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7517213rdf:typepubmed:Citationlld:pubmed
pubmed-article:7517213lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7517213lifeskim:mentionsumls-concept:C0024790lld:lifeskim
pubmed-article:7517213lifeskim:mentionsumls-concept:C0443211lld:lifeskim
pubmed-article:7517213lifeskim:mentionsumls-concept:C1553412lld:lifeskim
pubmed-article:7517213lifeskim:mentionsumls-concept:C1548328lld:lifeskim
pubmed-article:7517213pubmed:issue1lld:pubmed
pubmed-article:7517213pubmed:dateCreated1994-8-4lld:pubmed
pubmed-article:7517213pubmed:abstractTextPeripheral blood T lymphocytes obtained from two patients with paroxysmal nocturnal hemoglobinuria (PNH) were immortalized with human T-lymphotropic virus type 1 (HTLV-1). These cells showed interleukin-2 (IL-2)-dependent cell growth in culture. Cell surface analysis showed that they had the phenotype of a helper/inducer T subset that was positive for CD2, CD3, and CD4, but negative for CD8, similar to adult T-cell leukemia cells induced by HTLV-1. These cell lines lacked glycosylphosphatidylinositol (GPI)-anchored proteins, CDw52, CD55 (decay-accelerating factor; DAF), and CD59 on the cell surface, whereas intracellular DAF protein was detected. These T-subset cell lines with a PNH phenotype did not synthesize GPI anchor, whereas a control cell line, similarly prepared from the T cells of a healthy volunteer, produced the anchor. The control cells expressed CDw52, DAF, and CD59 on the cell surface and showed the phenotype of a helper/inducer subset. Southern blot analysis confirmed the clonality of each cell line. These CD4+ T-cell lines with a PNH phenotype and a subset-matched control counterpart could be a useful model for PNH investigation.lld:pubmed
pubmed-article:7517213pubmed:languageenglld:pubmed
pubmed-article:7517213pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7517213pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7517213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7517213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7517213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7517213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7517213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7517213pubmed:statusMEDLINElld:pubmed
pubmed-article:7517213pubmed:monthJullld:pubmed
pubmed-article:7517213pubmed:issn0006-4971lld:pubmed
pubmed-article:7517213pubmed:authorpubmed-author:TakatsukiKKlld:pubmed
pubmed-article:7517213pubmed:authorpubmed-author:KagimotoTTlld:pubmed
pubmed-article:7517213pubmed:authorpubmed-author:KawaguchiTTlld:pubmed
pubmed-article:7517213pubmed:authorpubmed-author:HidakaMMlld:pubmed
pubmed-article:7517213pubmed:authorpubmed-author:HorikawaKKlld:pubmed
pubmed-article:7517213pubmed:authorpubmed-author:IwamotoNNlld:pubmed
pubmed-article:7517213pubmed:authorpubmed-author:SanadaIIlld:pubmed
pubmed-article:7517213pubmed:authorpubmed-author:NakakumaHHlld:pubmed
pubmed-article:7517213pubmed:authorpubmed-author:NagakuraSSlld:pubmed
pubmed-article:7517213pubmed:issnTypePrintlld:pubmed
pubmed-article:7517213pubmed:day1lld:pubmed
pubmed-article:7517213pubmed:volume84lld:pubmed
pubmed-article:7517213pubmed:ownerNLMlld:pubmed
pubmed-article:7517213pubmed:authorsCompleteYlld:pubmed
pubmed-article:7517213pubmed:pagination309-14lld:pubmed
pubmed-article:7517213pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:meshHeadingpubmed-meshheading:7517213-...lld:pubmed
pubmed-article:7517213pubmed:year1994lld:pubmed
pubmed-article:7517213pubmed:articleTitleInterleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients.lld:pubmed
pubmed-article:7517213pubmed:affiliationSecond Department of Internal Medicine, Kumamoto University School of Medicine, Japan.lld:pubmed
pubmed-article:7517213pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7517213pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7517213lld:pubmed